The global genome editing market is on the brink of a revolutionary expansion, with forecasts predicting its value will surge from USD 6.2 billion in 2024 to an astonishing USD 26.5 billion by 2034. This growth trajectory represents a remarkable compound annual growth rate (CAGR) of 15.7%. A key driver of this market boom is …